
SSII
Healthcare · Medical Devices · $332.8M market cap
$1.66+0.34 (+25.8%)Nov 13, 4:29 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 17, 2026 · upcoming | Time not confirmed | -0.01 | — | — |
| Aug 13, 2026 | Before the open | -0.01 | -0.01 | 0.0% |
| May 14, 2026 | After the close | — | -0.02 | — |
| Mar 10, 2026 | After the close | — | -0.01 | — |
| Oct 28, 2025 | Time not confirmed | — | -0.02 | — |
| Aug 7, 2025 | Time not confirmed | — | -0.00 | — |
| May 13, 2025 | Before the open | — | -0.03 | — |
| Mar 20, 2025 | After the close | — | -0.01 | — |
| Nov 11, 2024 | Before the open | — | -0.04 | — |
| Aug 12, 2024 | After the close | — | -0.02 | — |
| May 15, 2024 | Before the open | — | -0.02 | — |
| Mar 22, 2024 | After the close | — | -0.09 | — |
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops…